DRTECH Corporation
Financials
Valuation Metrics
DRTECH Corporation's Market Cap is ₩655B. At end of 2025 it was ₩1757B. Ranked #1595 of 2,421 in KR market (top 66%), #943 of 1,640 on KOSDAQ (top 57%), #64 of 96 in Health Care Equipment & Services (top 67%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 65.53B KRW | KR#1,595/2,421 Sec#64/96 |
| Revenue | 126.23B KRW | KR#1,279/2,421 Sec#21/96 |
| Net Income | -12.53B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 235.84B KRW | KR#1,190/2,421 Sec#30/96 |
| Net Assets | 84.82B KRW | KR#1,539/2,421 Sec#44/96 |
| Employees | 367 | KR#657/2,421 Sec#15/96 |
| Value | ||
| P/B | 0.77x | KR#1,222/2,421 Sec#26/96 |
| P/S | 0.52x | KR#947/2,421 Sec#9/96 |
| FCF Yield | -40.60% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | -14.78% | KR#2,019/2,421 Sec#72/96 |
| ROA | -5.31% | KR#1,947/2,421 Sec#65/96 |
| Op. Margin | -7.94% | KR#1,942/2,421 Sec#60/96 |
| Revenue Growth | 11.84% | KR#813/2,421 Sec#41/96 |
| Financial Health | ||
| Debt Ratio | 178.06% | KR#2,027/2,421 Sec#87/96 |
| Total Debt | 105.97B KRW | KR#706/2,421 Sec#13/96 |
| FCF | -26.61B KRW | KR#1,961/2,421 Sec#76/96 |
| Cash | 36.28B KRW | KR#895/2,421 Sec#23/96 |
| Current Ratio | 1.94x | KR#895/2,421 Sec#51/96 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,421 Sec—/96 |
| Performance | ||
| 1Y Return | -65.11% | KR#2,263/2,421 Sec#88/96 |
| 1M Return | -18.23% | KR#2,286/2,421 Sec#88/96 |
| From 52W High | -66.81% | KR#2,111/2,421 Sec#75/96 |
| 1Y MDD | -68.35% | KR#1,917/2,421 Sec#68/96 |
| Trading | ||
| Volume | 47,889 shares | KR#1,151/2,421 Sec#40/96 |
| Trading Value | 189.5M KRW | KR#1,297/2,421 Sec#50/96 |
| Foreign Own. | 0.00% | KR—/2,421 Sec—/96 |
| Per Share | ||
| EPS | -751 KRW | KR—/2,421 Sec—/96 |
| BPS | 5,080 KRW | KR#1,477/2,421 Sec#36/96 |
Company Info
DRTECH, established in 2000 and listed on KOSDAQ in 2016, is a digital diagnostic imaging solution company. Leveraging over 20 years of imaging diagnosis technology, it uniquely offers total solutions encompassing all X-ray systems and components, integrating system, software, and detector into a unified platform. The company maintains global operations with approximately 80% of its sales from overseas and is expanding its market influence with digital mammography upgrade solutions and a full product lineup. DRTECH is headquartered in Seongnam-si, Gyeonggi-do.